期刊文献+

十二指肠神经内分泌癌8例临床分析 被引量:1

Duodenal neuroendocrine carcinoma: A clinical analysis of 8 cases
暂未订购
导出
摘要 目的探讨十二指肠神经内分泌癌(duodenal neuroendocrine carcinoma,DNEC)的临床病理学特征与外科治疗效果。方法回顾性分析2009-2012年于我院治疗的8例DNEC的临床病理学特征与外科治疗效果并复习文献。结果 8例DNEC中,男性5例,女性3例;发病年龄28~80岁,平均年龄53岁;主要临床表现为皮肤巩膜黄染5例,上腹及腰背部疼痛5例,黑便1例,1例无症状;肿瘤位于十二指肠降段4例,乳头3例,水平段1例;腹部影像呈多样性,CT可呈十二指肠乳头或相应部位肿物。4例行胰十二指肠切除术,2例行内窥镜逆行胆总管造影并胆管支架置入术(ERCP),2例行胃肠吻合并超声引导经皮经肝胆道造影置管引流术(PTCD);术后随访3~40个月,4例行根治性切除患者均长期存活,4例行姑息性治疗患者均已死亡。结论十二指肠神经内分泌癌呈浸润性生长,应积极手术治疗以改善患者预后。 Objective To study the clinicopathological features of duodenal neuroendocrine carcinoma(DNEC) and its surgical treatment outcome.Methods Clinical data about 8 DNEC patients and its surgical treatment outcome were retrospectively analyzed with its related literature reviewed.Results Of the 8 DNEC patients,5 were males and 3 were females.They developed DNEC at the age of 53 years(mean 28-80 years).DNEC was mainly manifested as jaundice in 5 cases,as abdominal pain in 5 cases,and as melena in 1 case.No symptom was observed in 1 case.The tumor was located at descendant duodenum in 4 cases,at duodenal papilla in 3 cases,at horizontal duodenum in 1 case.CT scan showed DNEC at duodenal papilla or its corresponding sites.Of the 8 patients,4 underwent pancreaticoduodenectomy,2 underwent ERCP and bile duct stenting,2 underwent gastroenterostomy and PTCD.The patients were followed up for 3-40 months after operation.The 4 patients who underwent radical excision were still alive while the other 4 patients who underwent palliative therapy died.Conclusion DNEC is an infiltrative growth tumor.Surgical resection can improve the prognosis of its patients.
出处 《解放军医学院学报》 CAS 2013年第2期140-141,147,共3页 Academic Journal of Chinese PLA Medical School
关键词 十二指肠 神经内分泌癌 诊断 治疗 duodenum neuroendocrine carcinoma diagnosis treatment
  • 相关文献

参考文献4

二级参考文献33

  • 1Eswaran Selvakumar,Shanmugasundaram Rajendran,Tirupporur Govindaswamy Balachandar,Devy Gounder Kannan,Satyanesan Jeswanth,Palaniappan Ravichandran,Rajagopal Surendran.Neuroendocrine carcinoma of the ampulla of Vater:a clinicopathologic evaluation[J].Hepatobiliary & Pancreatic Diseases International,2008,7(4):422-425. 被引量:8
  • 2Yaov JC,Hassan M,Phan A,et al.One hundred years after "carcinoid ":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.J Clin Oncol,2008,26(18):3063-3072.
  • 3Yao JC,Shah MH,Ito T,et al.Everolimus for advanced pancreatic neuroendocrine tumors.N Engl J Med,2011,364(6):514-523.
  • 4Raymond E,Dahan L,Raoul JL,et al.Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.N Engl J Med,2011,36(6):501-513.
  • 5Kl(o)ppel G,Couvelard A,Perren A,et al.ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors:towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.Neuroendocrinology,2009,90 (2):162-166.
  • 6Klimstra DS,Modlin IR,Adsay NV,et al.Pathology reporting of neuroendocrine tumors:application of the Delphic consensus process to the development of a minimum pathology data set.Am J Surg Pathol,2010,34(3):300-313.
  • 7Bosman FT,Carneiro F,Hruban RH,et al.WHO classification of tumours of the digestive system.Lyon:IARC Press,2010.
  • 8Oberndorfer S.Karzinoide tumoren des dunndarms.Frankf ZPatrol,1907,1:426-432.
  • 9Williams ED,Siebenmann RE,Sobin LH.Histological typing of endocrine tumours.Geneva:World Health Organization,1980.
  • 10Hamilton SR,Aaltonen LA.World Health Organization classification of tumours.Pathology and genetics of tumours of the digestive system.Lyon:IARC Press,2000.

共引文献310

同被引文献3

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部